{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:34:46Z","timestamp":1786736086506,"version":"build-2736575974"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Dermatol"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/ijd.ijd_505_18","type":"journal-article","created":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T01:35:27Z","timestamp":1578879327000},"page":"38","source":"Crossref","is-referenced-by-count":5,"title":["Therapeutic efficacy of the combination therapy of corticosteroids and 5-aminosalicylic acid for treatment of pyoderma gangrenosum with ulcerative colitis"],"prefix":"10.4103","volume":"65","author":[{"given":"Li","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0019-5154.275770-1","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jaad.2015.06.021","article-title":"Pathophysiology of pyoderma gangrenosum (PG): An updated review","author":"Braswell","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0019-5154.275770-2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s40257-017-0251-7","article-title":"Pyoderma gangrenosum: An update on pathophysiology, diagnosis and treatment","author":"Alavi","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0019-5154.275770-3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jaad.2004.10.006","article-title":"Treatment recommendations for pyoderma gangrenosum: An evidence-based review of the literature based on more than 350 patients","author":"Reichrath","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0019-5154.275770-4","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/apt.12431","article-title":"Systematic review: IBD-associated pyoderma gangrenosum in the biologic era, the response to therapy","author":"Agarwal","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"key-10.4103\/0019-5154.275770-5","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.crohns.2010.10.006","article-title":"Pyoderma gangrenosum in inflammatory bowel disease: The experience at Mater Health Services' Adult Hospital 1998-2009","author":"Polcz","year":"2011","journal-title":"J Crohns Colitis"},{"key":"key-10.4103\/0019-5154.275770-6","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ibd.20807","article-title":"Mucocutaneous manifestations in inflammatory bowel disease","author":"Y\u00fcksel","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"key-10.4103\/0019-5154.275770-7","first-page":"251","article-title":"Pyoderma gangrenosum","author":"Tan","year":"2007","journal-title":"Med J Malaysia"},{"key":"key-10.4103\/0019-5154.275770-8","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1365-2230.2006.02093.x","article-title":"Behcet's disease-like presentation of bullous pyoderma gangrenosum associated with Crohn's disease","author":"Akay","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"key-10.4103\/0019-5154.275770-9","doi-asserted-by":"crossref","first-page":"422","DOI":"10.5021\/ad.2010.22.4.422","article-title":"A case of pyoderma gangrenosum with ulcerative colitis treated with mesalazine","author":"Lee","year":"2010","journal-title":"Ann Dermatol"},{"key":"key-10.4103\/0019-5154.275770-10","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0140-6736(05)79419-8","article-title":"Pyoderma gangrenosum","author":"Hambin","year":"1998","journal-title":"Lancet"},{"key":"key-10.4103\/0019-5154.275770-11","doi-asserted-by":"crossref","unstructured":"Bressler B, Marshall JK, Bernstein CN, Bitton A, Jones J, Leontiadis GI, et al. Clinical practice guidelines for the medical management of nonhospitalized ulcerative colitis: The Toronto consensus. Gastroenterology 2015;148:1035-58.e3.","DOI":"10.1053\/j.gastro.2015.03.001"},{"key":"key-10.4103\/0019-5154.275770-12","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/j.1365-2133.2007.08202.x","article-title":"Pyoderma gangrenosum and interleukin 8","author":"Oka","year":"2007","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0019-5154.275770-13","first-page":"262","article-title":"Successful treatment of pyoderma gangrenosum with topical 5-aminosalicylic acid","author":"Sanders","year":"1993","journal-title":"Cutis"},{"key":"key-10.4103\/0019-5154.275770-14","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/j.1468-3083.2009.03199.x","article-title":"Pyoderma gangrenosum: An updated review","author":"Ruocco","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.4103\/0019-5154.275770-15","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/gut.2005.074815","article-title":"Infliximab for the treatment of pyoderma gangrenosum: A randomised, double blind, placebo controlled trial","author":"Brooklyn","year":"2006","journal-title":"Gut"}],"container-title":["Indian Journal of Dermatology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:37:08Z","timestamp":1786732628000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.IJD_505_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"alternative-id":["275770"],"URL":"https:\/\/doi.org\/10.4103\/ijd.ijd_505_18","relation":{},"ISSN":["0019-5154"],"issn-type":[{"value":"0019-5154","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}